All Stories

  1. ESC Working Group on Cellular Biology of the Heart

    Article • Cardiovascular Research, January 2019, Oxford University Press (OUP)

    Professor Joost PG Sluijter

  2. Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology

    Article • Cardiovascular Research, November 2017, Oxford University Press (OUP)

    Professor Joost PG Sluijter, Professor Raymond Schiffelers

  3. Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure

    Article • European Heart Journal, April 2016, European Society of Cardiology

    Professor Joost PG Sluijter

  4. Intramyocardial stem cell injection: go(ne) with the flow

    Article • European Heart Journal, February 2016, European Society of Cardiology

    Professor Joost PG Sluijter

  5. Gelatin Microspheres as Vehicle for Cardiac Progenitor Cells Delivery to the Myocardium

    Article • Advanced Healthcare Materials, February 2016, Wiley

    Professor Joost PG Sluijter

  6. Cardiac Stem Cell Treatment in Myocardial InfarctionNovelty and Significance

    Article • Circulation Research, February 2016, Wolters Kluwer Health

    Professor Joost PG Sluijter, Professor Malcolm R Macleod

  7. Cardiac derived ECM enhances cardiogenic properties of Human Cardiac Progenitor Cells

    Article • Frontiers in Bioengineering and Biotechnology, January 2016, Frontiers

    Professor Joost PG Sluijter

  8. Increased local delivery of antagomir therapeutics to the rodent myocardium using ultrasound and microbubbles

    Article • Journal of Controlled Release, January 2016, Elsevier

    Professor Joost PG Sluijter

  9. Cardiac Regeneration and microRNAs: Regulators of Pluripotency, Reprogramming, and Cardiovascular Lineage Commitment

    Article • December 2015, Springer Science + Business Media

    Professor Joost PG Sluijter

  10. Xenotransplantation of Human Cardiomyocyte Progenitor Cells Does Not Improve Cardiac Function in a Porcine Model of Chronic Ischemic Heart Failure. Results from a Randomized, Blinded, Placebo Controlled Trial

    Article • PLoS ONE, December 2015, PLOS

    Professor Joost PG Sluijter

  11. Corrigendum: Gap junctional protein Cx43 is involved in the communication between extracellular vesicles and mammalian cells

    Article • Scientific Reports, October 2015, Nature

    Professor Joost PG Sluijter, Sandra I Anjo

  12. Gap junctional protein Cx43 is involved in the communication between extracellular vesicles and mammalian cells

    Article • Scientific Reports, August 2015, Nature

    Professor Joost PG Sluijter, Dr Henrique Girao

  13. Stem Cell Aging and Age-Related Cardiovascular Disease: Perspectives of Treatment by Ex-vivo Stem Cell Rejuvenation

    Article • Current Drug Targets, August 2015, Bentham Science Publishers

    Professor Rosalinda Madonna, Professor Joost PG Sluijter

  14. Epicardial application of cardiac progenitor cells in a 3D-printed gelatin/hyaluronic acid patch preserves cardiac function after myocardial infarction

    Article • Biomaterials, August 2015, Elsevier

    Professor Joost PG Sluijter

  15. MicroRNA-132/212 family enhances arteriogenesis after hindlimb ischaemia through modulation of the Ras-MAPK pathway

    Article • Journal of Cellular and Molecular Medicine, May 2015, Wiley

    Professor Joost PG Sluijter

  16. MicroRNA Therapeutics for Cardiac Regeneration

    Article • Mini-Reviews in Medicinal Chemistry, April 2015, Bentham Science Publishers

    Professor Joost PG Sluijter

  17. A snapshot of genetic and epigenetic basis of arrhythmia and heart failure

    Article • Frontiers in Genetics, March 2015, Frontiers

    Professor Joost PG Sluijter

  18. Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice

    Article • Scientific Reports, February 2015, Nature

    Professor Joost PG Sluijter

  19. Cardiac Allograft Vasculopathy: A Donor or Recipient Induced Pathology?

    Article • Journal of Cardiovascular Translational Research, February 2015, Springer Science + Business Media

    Professor Joost PG Sluijter

  20. Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigs

    Article • European Journal of Clinical Investigation, January 2015, Wiley

    Professor Joost PG Sluijter

  21. Ultrasound and Microbubble-Induced Local Delivery of MicroRNA-Based Therapeutics

    Article • Ultrasound in Medicine & Biology, January 2015, Elsevier

    Professor Joost PG Sluijter

  22. Different types of cultured human adult Cardiac Progenitor Cells have a high degree of transcriptome similarity

    Article • Journal of Cellular and Molecular Medicine, October 2014, Wiley

    Professor Joost PG Sluijter

  23. Novel therapeutic strategies for cardioprotection

    Article • Pharmacology & Therapeutics, October 2014, Elsevier

    Professor Joost PG Sluijter

  24. Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges

    Article • Clinical Science, September 2014, Portland Press Ltd.

    Professor Joost PG Sluijter

  25. Wnt/β-Catenin Signaling during Cardiac Development and Repair

    Article • Journal of Cardiovascular Development and Disease, May 2014, MDPI AG

    Professor Joost PG Sluijter

  26. Inhibition of miR-25 improves cardiac contractility in the failing heart

    Article • Nature, March 2014, Nature

    Professor Joost PG Sluijter

  27. Layer-Specific Radiofrequency Ultrasound-Based Strain Analysis in a Porcine Model of Ischemic Cardiomyopathy Validated by a Geometric Model

    Article • Ultrasound in Medicine & Biology, February 2014, Elsevier

    Professor Joost PG Sluijter

  28. Sustained Delivery of Insulin-Like Growth Factor-1/Hepatocyte Growth Factor Stimulates Endogenous Cardiac Repair in the Chronic Infarcted Pig Heart

    Article • Journal of Cardiovascular Translational Research, January 2014, Springer Science + Business Media

    Professor Joost PG Sluijter

  29. Drug Delivery: A Fast pH-Switchable and Self-Healing Supramolecular Hydrogel Carrier for Guided, Local Catheter Injection in the Infarcted Myocardium (Adv. Healthcare Mater. 1/2014)

    Article • Advanced Healthcare Materials, January 2014, Wiley

    Professor Joost PG Sluijter

  30. Expanding Mouse Ventricular Cardiomyocytes Through GSK-3 Inhibition

    Article • December 2013, Wiley

    Professor Joost PG Sluijter

  31. Concise Review: Engineering Myocardial Tissue: The Convergence of Stem Cells Biology and Tissue Engineering Technology

    Article • Stem Cells, December 2013, Wiley

    Professor Joost PG Sluijter

  32. Assessment of coronary microvascular resistance in the chronic infarcted pig heart

    Article • Journal of Cellular and Molecular Medicine, August 2013, Wiley

    Professor Joost PG Sluijter

  33. A Fast pH-Switchable and Self-Healing Supramolecular Hydrogel Carrier for Guided, Local Catheter Injection in the Infarcted Myocardium

    Article • Advanced Healthcare Materials, June 2013, Wiley

    Professor Joost PG Sluijter

  34. Targeting cell death in the reperfused heart: Pharmacological approaches for cardioprotection

    Article • International Journal of Cardiology, May 2013, Elsevier

    Professor Joost PG Sluijter

  35. microRNA-1 enhances the angiogenic differentiation of human cardiomyocyte progenitor cells

    Article • Journal of Molecular Medicine, April 2013, Springer Science + Business Media

    Professor Joost PG Sluijter

  36. SUSTAINED DELIVERY OF INSULIN-LIKE GROWTH FACTOR-1/HEPATOCYTE GROWTH FACTOR PROMOTES ENDOGENOUS CARDIAC REPAIR AND REGENERATION IN THE CHRONIC ISCHEMIC HEART

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Professor Joost PG Sluijter

  37. Lack of haptoglobin results in unbalanced VEGFα/angiopoietin-1 expression, intramural hemorrhage and impaired wound healing after myocardial infarction

    Article • Journal of Molecular and Cellular Cardiology, March 2013, Elsevier

    Professor Joost PG Sluijter

  38. MicroRNAs in Cardiovascular Regenerative Medicine: Directing Tissue Repair and Cellular Differentiation

    Article • ISRN Vascular Medicine, January 2013, Hindawi Publishing Corporation

    Professor Joost PG Sluijter

  39. MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells

    Article • Journal of Molecular and Cellular Cardiology, December 2012, Elsevier

    Professor Joost PG Sluijter

  40. Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiency

    Article • Journal of Cellular and Molecular Medicine, October 2012, Wiley

    Professor Joost PG Sluijter

  41. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs

    Article • EMBO Molecular Medicine, October 2012, EMBO

    Professor Joost PG Sluijter

  42. MiR‐155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP‐16

    Article • Journal of Cellular and Molecular Medicine, September 2012, Wiley

    Professor Joost PG Sluijter

  43. Human cardiomyocyte progenitor cells: a short history of nearly everything

    Article • Journal of Cellular and Molecular Medicine, July 2012, Wiley

    Professor Joost PG Sluijter

  44. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia–reperfusion in vivo

    Article • Basic Research in Cardiology, May 2012, Springer Science + Business Media

    Professor Joost PG Sluijter

  45. Sequential use of human-derived medium supplements favours cardiovascular tissue engineering

    Article • Journal of Cellular and Molecular Medicine, April 2012, Wiley

    Professor Joost PG Sluijter

  46. Cardiac tissue engineering using tissue printing technology and human cardiac progenitor cells

    Article • Biomaterials, February 2012, Elsevier

    Professor Joost PG Sluijter

  47. Cellular Therapy for the Infarcted Myocardium

    Article • January 2012, Springer Science + Business Media

    Professor Joost PG Sluijter

  48. Letter by Sluijter et al Regarding Article, “Human Cardiac Stem Cell Differentiation Is Regulated by a Mircrine Mechanism”

    Article • Circulation, October 2011, Wolters Kluwer Health

    Professor Joost PG Sluijter

  49. Decreased Mechanical Properties of Heart Valve Tissue Constructs Cultured in Platelet Lysate as Compared to Fetal Bovine Serum

    Article • Tissue Engineering Part C Methods, May 2011, Mary Ann Liebert Inc

    Professor Joost PG Sluijter

  50. CLINICAL RELEVANCE OF ISCHEMIC LARGE ANIMAL MODELS IN STEM CELL THERAPY; AN OVERVIEW AND META-ANALYSIS.

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Professor Joost PG Sluijter, Dr Pierfrancesco Agostoni

  51. Tissue Engineering for Cardiac Regeneration

    Article • January 2011, Springer Science + Business Media

    Professor Joost PG Sluijter

  52. Environmental regulation of valvulogenesis: implications for tissue engineering

    Article • European Journal of Cardio-Thoracic Surgery, January 2011, Oxford University Press (OUP)

    Professor Joost PG Sluijter

  53. Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium

    Article • The International Journal of Cardiovascular Imaging, June 2010, Springer Science + Business Media

    Professor Joost PG Sluijter

  54. MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1

    Article • Journal of Cellular and Molecular Medicine, June 2010, Wiley

    Professor Joost PG Sluijter

  55. Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application

    Article • Journal of Cellular and Molecular Medicine, May 2010, Wiley

    Prof. Lucio Barile, Professor Joost PG Sluijter

  56. Active Wnt signaling in response to cardiac injury

    Article • Basic Research in Cardiology, April 2010, Springer Science + Business Media

    Professor Joost PG Sluijter

  57. Platelet-Lysate as an Autologous Alternative for Fetal Bovine Serum in Cardiovascular Tissue Engineering

    Article • Tissue Engineering Part A, April 2010, Mary Ann Liebert Inc

    Professor Joost PG Sluijter

  58. Hyperpolarization Induces Differentiation in Human Cardiomyocyte Progenitor Cells

    Article • Stem Cell Reviews and Reports, March 2010, Springer Science + Business Media

    Professor Joost PG Sluijter

  59. Foetal and adult cardiomyocyte progenitor cells have different developmental potential

    Article • Journal of Cellular and Molecular Medicine, March 2010, Wiley

    Professor Joost PG Sluijter

  60. Human cardiomyocyte progenitor cell-derived cardiomyocytes display a maturated electrical phenotype

    Article • Journal of Molecular and Cellular Cardiology, January 2010, Elsevier

    Professor Joost PG Sluijter

  61. Cell Therapy for Myocardial Regeneration

    Article • Current Molecular Medicine, April 2009, Bentham Science Publishers

    Professor Joost PG Sluijter

  62. The Potential of Modulating Small RNA Activity In Vivo

    Article • Mini-Reviews in Medicinal Chemistry, February 2009, Bentham Science Publishers

    Professor Joost PG Sluijter

  63. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology

    Article • Nature Protocols, February 2009, Nature

    Professor Joost PG Sluijter

  64. Stem Cells from In- or Outside of the Heart: Isolation, Characterization, and Potential for Myocardial Tissue Regeneration

    Article • Pediatric Cardiology, January 2009, Springer Science + Business Media

    Professor Joost PG Sluijter

  65. Caveolin-1 Influences Vascular Protease Activity and Is a Potential Stabilizing Factor in Human Atherosclerotic Disease

    Article • PLoS ONE, July 2008, PLOS

    Professor Joost PG Sluijter

  66. TGF-β1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro

    Article • Stem Cell Research, June 2008, Elsevier

    Professor Joost PG Sluijter

  67. Balance between Angiopoietin-1 and Angiopoietin-2 Is in Favor of Angiopoietin-2 in Atherosclerotic Plaques with High Microvessel Density

    Article • Journal of Vascular Research, January 2008, Karger Publishers

    Professor Joost PG Sluijter

  68. Isolation and expansion of resident cardiac progenitor cells

    Article • Expert Review of Cardiovascular Therapy, January 2007, Taylor & Francis

    Professor Joost PG Sluijter

  69. Vascular remodeling and protease inhibition—bench to bedside

    Article • Cardiovascular Research, February 2006, European Society of Cardiology

    Professor Joost PG Sluijter

  70. Quantitative Real-Time PCR

    Article • January 2006, Springer Science + Business Media

    Professor Joost PG Sluijter

  71. Modulation of Collagen Turnover in Cardiovascular Disease

    Article • Current Pharmaceutical Design, July 2005, Bentham Science Publishers

    Professor Joost PG Sluijter

  72. Increase in Collagen Turnover But Not in Collagen Fiber Content Is Associated with Flow-Induced Arterial Remodeling

    Article • Journal of Vascular Research, January 2004, Karger Publishers

    Professor Joost PG Sluijter

  73. Furin and membrane type-1 metalloproteinase mRNA levels and activation of metalloproteinase-2 are associated with arterial remodeling

    Article • FEBS Letters, July 2001, Wiley

    Professor Joost PG Sluijter